Data as of Jul 25
| -0.0428 / -3.68%|
The 1 analysts offering 12-month price forecasts for Prima BioMed Ltd have a median target of 0.00, with a high estimate of 0.00 and a low estimate of 0.00. The median estimate represents a -99.89% decrease from the last price of 1.12.
The current consensus among 1 polled investment analysts is to Hold stock in Prima BioMed Ltd. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.